US2015219595A1PendingUtilityA1
Process for Analyzing Sample by Capillary Electrophoresis Method
Assignee: NAT INST OF ADVANCED IND SCIENPriority: Sep 4, 2006Filed: Apr 14, 2015Published: Aug 6, 2015
Est. expirySep 4, 2026(~0.1 yrs left)· nominal 20-yr term from priority
G01N 27/447G01N 27/44756
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for analyzing a sample by a capillary electrophoresis method is provided that allows for high analytic precision and reduction in apparatus size, and can be readily carried out by electrophoresing a complex of a sample and an anionic group-containing compound in the capillary channel, wherein the capillary channel includes an A layer that is coated on an inner wall thereof and a B layer that is coated on the A layer, where the A and B layers are as described.
Claims
exact text as granted — not AI-modified1 - 18 . (canceled)
19 . A process for analyzing hemoglobin in a sample by a capillary electrophoresis method comprising:
providing a sample comprising hemoglobin, preparing a capillary channel for capillary electrophoresis, and performing electrophoretic separation of a chemical complex comprising the hemoglobin and a first anionic compound that is present in a running buffer solution at a pH in a range of 4.5 to 6 in the capillary channel, wherein the capillary channel comprises an inner wall coated with an A layer and a B layer that coats the A layer, wherein the A layer is covalently bonded to the inner wall and comprises at least one of a nonpolar polymer and a cationic compound, and the B layer comprises a second anionic compound, wherein the first anionic compound may be the same or different from the second anionic compound.
20 . The process of claim 19 , wherein the nonpolar polymer of the A layer is a silicone polymer.
21 . The process of claim 20 , wherein the silicone polymer is selected from the group consisting of a polysiloxane and a polysilazane.
22 . The process of claim 20 , wherein the silicone polymer is selected from the group consisting of a polydialkylsiloxane, a polydialkylsilazane, a polyarylsiloxane, a polyarylsilazane, a polyalkylarylsiloxane, a polydiarylsiloxane, a cyclic siloxane and a cyclic silazane.
23 . The process of claim 19 , wherein the cationic compound of the A layer comprises a silylation agent containing at least one selected from an amino group and an ammonium group.
24 . The process of claim 23 , wherein the silylation agent is selected from the group consisting of N-(2-diaminoethyl)-3-propyltrimethoxysilane, aminophenoxydimethylvinylsilane, 3-aminopropyldiisopropylethoxysilane, 3-aminopropylmethylbis(trimethylsiloxy)silane, 3-aminopropylpentamethyldisiloxane, 3-aminopropylsilanetriol, bis(p-aminophenoxy)dimethylsilane, 1,3-bis(3-aminopropyl)tetramethyldisiloxane, bis(dimethylamino)dimethylsilane, bis(dimethylamino)vinylmethylsilane, bis(2-hydroxyethyl)-3-aminopropyltriethoxysilane, 3-cyanopropyl(diisopropyl)dimethylaminosilane, (aminoethylaminomethyl)phenethyltrimethoxysilane, N-methylaminopropyltriethoxysilane, tetrakis(diethylamino)silane, tris(dimethylamino)chlorosilane and tris(dimethylamino)silane.
25 . The process of claim 19 , wherein at least one of the first anionic compound and the second anionic compound is an anionic polysaccharide.
26 . The process of claim 25 , wherein the anionic polysaccharide is at least one selected from the group consisting of a sulfated polysaccharide, a carboxylated polysaccharide, a sulfonated polysaccharide and a phosphorylated polysaccharide.
27 . The process of claim 26 , wherein the sulfated polysaccharide is chondroitin sulfate.
28 . The process of claim 19 , wherein the first anionic compound is chondroitin sulfate.
29 . The process of claim 19 , wherein the second anionic compound is chondroitin sulfate.
30 . The process of claim 19 , wherein the A layer comprises a nonpolar polymer.
31 . The process of claim 19 , wherein the A layer comprises a cationic compound.
32 . The process of claim 19 , wherein the A layer consists of a cationic compound.
33 . The process of claim 19 , wherein the hemoglobin is a glycated hemoglobin.
34 . The process of claim 19 , wherein the hemoglobin is HbA1c.Join the waitlist — get patent alerts
Track US2015219595A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.